<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20316" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Dowling-Degos Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rice</surname>
            <given-names>Ashley S.</given-names>
          </name>
          <aff>CUSOM/Sampson Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cook</surname>
            <given-names>Christopher</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ashley Rice declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christopher Cook declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>16</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20316.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Dowling-Degos disease is a rare autosomal dominant disorder characterized by acquired reticular hyperpigmentation in flexural sites. Hyperpigmentation is often recalcitrant to therapy and may lead to significant psychosocial distress, especially in those with concomitant acne-like scarring. This activity reviews the evaluation and management of Dowling Degos disease and highlights the role of the interprofessional team in improving care for this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of Dowling-Degos disease.</p></list-item><list-item><p>Outline the typical presentation of a patient with Dowling-Degos disease.</p></list-item><list-item><p>Review treatment and psychosocial considerations for patients with Dowling-Degos disease.</p></list-item><list-item><p>Explain the importance of improving care coordination among the interprofessional team to enhance the delivery of care for patients with Dowling-Degos disease.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20316&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20316">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20316.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Dowling-Degos disease (DDD) is a rare autosomal dominant disorder, classically characterized by acquired reticular hyperpigmentation in flexural sites.<xref ref-type="bibr" rid="article-20316.r1">[1]</xref>&#x000a0;Onset is typically after puberty and commonly occurs in the third to fourth decade of life. Mutations in genes involved in melanosome trafficking and melanocyte and keratinocyte proliferation, differentiation, and cellular communications have all&#x000a0;been implicated&#x000a0;as etiologies. Hyperpigmentation is often recalcitrant to treatment, as evidenced by the varying success of&#x000a0;topical and laser therapies.</p>
      </sec>
      <sec id="article-20316.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Classic DDD and <italic toggle="yes">Galli-Galli</italic> disease (a variant of DDD) are caused by a loss-of-function mutation in the non-helical head domain of the keratin 5 gene (KRT5), leading to only one functional copy&#x000a0;of KRT5.<xref ref-type="bibr" rid="article-20316.r2">[2]</xref>&#x000a0;Other genetic implications include mutations in POFUT1, POGLUT1, and PSENEN, which encode protein O-fucosyltransferase 1, protein O-glucosyltransferase 1, and presenilin enhancer protein 2 gene, respectively. POFUT1 and POGLUT1 mutations have been linked to a variant form of DDD that commonly involves non-flexural sites, while PSENEN mutations have been attributed to&#x000a0;a variant of DDD associated with hidradenitis suppurativa.<xref ref-type="bibr" rid="article-20316.r3">[3]</xref>,<xref ref-type="bibr" rid="article-20316.r4">[4]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-20316.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Since DDD was first described in 1938, there have been less than 50 cases reported in the literature.&#x000a0;DDD has no racial or gender predilection, and lesions typically present in the third to fourth decade of life.<xref ref-type="bibr" rid="article-20316.r5">[5]</xref> &#x000a0;</p>
      </sec>
      <sec id="article-20316.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Given that DDD is a disorder of hyperpigmentation, the main pathophysiology behind the disease fittingly involves melanosomal functioning. Intracellular transport, a function once believed to be reserved to microfilaments and microtubules, has been linked to keratins through studies elucidating the effect of&#x000a0;haploinsufficiency of keratin 5 on the organization of cell adhesion, melanosome uptake into keratinocytes, organelle transport, and nuclear anchorage. Specifically, the head domain of keratin 5 is believed to play a role in melanosome trafficking through its interaction with Hsc70, a chaperone protein involved in vesicle uncoating.<xref ref-type="bibr" rid="article-20316.r2">[2]</xref>&#x000a0;</p>
        <p>In addition, mutations in POFUT1 and POGLUT1 disrupt the Notch signaling pathway by affecting enzymes involved in post-translational modification. Mutations in PSENEN also affect the Notch signaling pathway by modifying an enhancer gene that encodes a component of y-secretase protein complex. The Notch signaling pathway plays an integral part in skin homeostasis by regulating the proliferation and differentiation of melanocytes and keratinocytes and mediating their interactions with one another.<xref ref-type="bibr" rid="article-20316.r3">[3]</xref><xref ref-type="bibr" rid="article-20316.r4">[4]</xref></p>
      </sec>
      <sec id="article-20316.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologically, DDD is characterized by an increase in pigmentation of the basal layer and downward elongation of the rete ridges with thinning of the underlying suprapapillary epithelium. This often appears filiform or antler-like when arising from the under surface of the epidermis and hair follicles. Dermal melanophages and a mild perivascular lymphohistiocytic infiltrate are also present.<xref ref-type="bibr" rid="article-20316.r5">[5]</xref>&#x000a0;<italic toggle="yes">Galli-Galli</italic> disease is a variant of DDD that has prominent suprabasal non-dyskeratotic acantholysis in addition to the classic histologic features previously described.<xref ref-type="bibr" rid="article-20316.r6">[6]</xref>&#x000a0;The importance of keratin 5 and Notch signaling in melanocyte and keratinocyte functioning is evidenced by the haphazard distribution of irregularly-shaped melanosomes and the irregular shape and size of keratinocytes on histopathology in patients with DDD.<xref ref-type="bibr" rid="article-20316.r3">[3]</xref></p>
      </sec>
      <sec id="article-20316.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with Dowling-Degos disease describe an abnormal darkening of the skin in their body folds and creases. Occasionally, patients report associated pruritus in these areas. On exam, reticulated&#x000a0;hyperpigmentation is seen in intertriginous areas and is composed of lentigo-like brown macules and small brown papules with variable hyperkeratosis. The hyperpigmentation progressively increases over time, first arising in the axilla and groin and subsequently appearing in the intergluteal and inframammary folds, neck, trunk, and inner arms and thighs.&#x000a0;<xref ref-type="bibr" rid="article-20316.r1">[1]</xref><xref ref-type="bibr" rid="article-20316.r2">[2]</xref><xref ref-type="bibr" rid="article-20316.r3">[3]</xref><xref ref-type="bibr" rid="article-20316.r4">[4]</xref><xref ref-type="bibr" rid="article-20316.r5">[5]</xref></p>
        <p>Comedone-like lesions on the back and neck, pitted perioral scars, and rarely palmar pits may also be present, especially in patients with an overlap of classic DDD and reticulate acropigmentation of Kitamura.<xref ref-type="bibr" rid="article-20316.r7">[7]</xref> Hidradenitis suppurative and epidermoid cysts have been described in&#x000a0;a variant of DDD.<xref ref-type="bibr" rid="article-20316.r4">[4]</xref>&#x000a0;Rarely, lesions are located in non-flexural areas, as seen in those with mutations in the POFUT1 and POGLUT1 genes.<xref ref-type="bibr" rid="article-20316.r3">[3]</xref>&#x000a0;In addition, there has been a single case report of biopsy-confirmed DDD presenting as multiple hypopigmented macules in the classic flexural distribution, highlighting the evolving spectrum of DDD.<xref ref-type="bibr" rid="article-20316.r7">[7]</xref></p>
      </sec>
      <sec id="article-20316.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>DDD is a clinical and histopathologic diagnosis, confirmed by the history and physical exam and skin biopsy findings. Additional laboratory tests or imaging is not required for diagnosis.<xref ref-type="bibr" rid="article-20316.r5">[5]</xref></p>
      </sec>
      <sec id="article-20316.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Topical hydroquinone, tretinoin, adapalene, and corticosteroids have been used with limited success. Case reports have shown success after treatment with Er:YAG laser followed by topical corticosteroids and fusidic acid. The Er:YAG laser is theorized to improve hyperpigmented areas by removing the abnormal proliferated epithelium&#x000a0;and allowing formation of new epidermal tissue from unaffected follicular epithelium.<xref ref-type="bibr" rid="article-20316.r8">[8]</xref><xref ref-type="bibr" rid="article-20316.r9">[9]</xref><xref ref-type="bibr" rid="article-20316.r10">[10]</xref></p>
      </sec>
      <sec id="article-20316.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>There are a variety of hyperpigmentation disorders that appear in the flexural areas that must be differentiated from DDD. They include&#x000a0;the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Reticulate acropigmentation of Kitamura
<list list-type="bullet"><list-item><p>Manifests as atrophic hyperpigmented papules that coalesce into a reticulated pattern. It is differentiated from DDD by its initial distribution on acral surfaces and onset in childhood.<xref ref-type="bibr" rid="article-20316.r11">[11]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Haber syndrome
<list list-type="bullet"><list-item><p>Initially presents as a photosensitive rosacea-like facial eruption during adolescence that is&#x000a0;followed by keratotic papules, comedone-like lesions, pitted scars, and reticulate hyperpigmentation on the trunk, proximal extremities, and axillae. The initial facial eruption supports the classification of Haber's disease as a separate entity from DDD.&#x000a0;<xref ref-type="bibr" rid="article-20316.r12">[12]</xref><xref ref-type="bibr" rid="article-20316.r13">[13]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Neurofibromatosis type 1
<list list-type="bullet"><list-item><p>Exhibits&#x000a0;axillary and inguinal freckling that mirrors the reticulated hyperpigmentation of DDD but becomes easily distinguishable from DDD with the development of multiple neurofibromas and other cutaneous manifestations.<xref ref-type="bibr" rid="article-20316.r14">[14]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Acanthosis nigricans
<list list-type="bullet"><list-item><p>Presents with velvety plaques that can be distinguished histologically from DDD by less elongation of the rete ridges and no follicular involvement.<xref ref-type="bibr" rid="article-20316.r15">[15]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20316.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Dowling-Degos disease is a rare genodermatosis that afflicts a small number of the worldwide population. While there is no significant mortality associated with Dowling-Degos disease, patients may experience significant distress and anxiety due to the skin manifestations associated with this&#x000a0;disease, especially those&#x000a0;who exhibit acne-like scarring. This can lead to significant psychiatric morbidity and a decrease in quality of life. In addition, the minimal efficacy of treatments in Dowling-Degos disease and medication adverse effects may further precipitate psychological stress. Thus, an interprofessional approach with collaboration between dermatologists, psychiatrists, family medicine physicians, and pharmacists is recommended to improve patient outcomes. [Level 4 and 5]<xref ref-type="bibr" rid="article-20316.r16">[16]</xref></p>
      </sec>
      <sec id="article-20316.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20316&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20316">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/dowling-degos-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20316">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20316/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20316">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20316.s13">
        <fig id="article-20316.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Dowling Degos Disease Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Dowling__Degos__disease__SV" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20316.s14">
        <title>References</title>
        <ref id="article-20316.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahajan</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Khopkar</surname>
                <given-names>US</given-names>
              </name>
              <name>
                <surname>Kharkar</surname>
                <given-names>VD</given-names>
              </name>
            </person-group>
            <article-title>Follicular Dowling-Degos Disease: A Rare Pigmentary Dermatosis.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2017</year>
            <season>Nov-Dec</season>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>487</fpage>
            <page-range>487-489</page-range>
            <pub-id pub-id-type="pmid">29204397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Betz</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Planko</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Eigelshoven</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hanneken</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pasternack</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Bussow</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Van Den Bogaert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wenzel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Braun-Falco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rutten</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Ruzicka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>N&#x000f6;then</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Magin</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Kruse</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease.</article-title>
            <source>Am J Hum Genet</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>78</volume>
            <issue>3</issue>
            <fpage>510</fpage>
            <page-range>510-9</page-range>
            <pub-id pub-id-type="pmid">16465624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basmanav</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Oprisoreanu</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Pasternack</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Thiele</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fritz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wenzel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gr&#x000f6;&#x000df;er</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wehner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fagerberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bygum</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Altm&#x000fc;ller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>R&#x000fc;tten</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parmentier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>El Shabrawi-Caelen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hafner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>N&#x000fc;rnberg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kruse</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schoch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hanneken</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Betz</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos disease.</article-title>
            <source>Am J Hum Genet</source>
            <year>2014</year>
            <month>Jan</month>
            <day>02</day>
            <volume>94</volume>
            <issue>1</issue>
            <fpage>135</fpage>
            <page-range>135-43</page-range>
            <pub-id pub-id-type="pmid">24387993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ralser</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Basmanav</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Tafazzoli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wititsuwannakul</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Delker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Danda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thiele</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Busch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pulimood</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Altm&#x000fc;ller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>N&#x000fc;rnberg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lacombe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hillen</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Wenzel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Frank</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Odermatt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Betz</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Mutations in &#x003b3;-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa.</article-title>
            <source>J Clin Invest</source>
            <year>2017</year>
            <month>Apr</month>
            <day>03</day>
            <volume>127</volume>
            <issue>4</issue>
            <fpage>1485</fpage>
            <page-range>1485-1490</page-range>
            <pub-id pub-id-type="pmid">28287404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Schanbacher</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>WP</given-names>
              </name>
            </person-group>
            <article-title>Dowling-Degos disease (reticulate pigmented anomaly of the flexures): a clinical and histopathologic study of 6 cases.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>462</fpage>
            <page-range>462-7</page-range>
            <pub-id pub-id-type="pmid">10071319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanneken</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>R&#x000fc;tten</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pasternack</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Eigelshoven</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>El Shabrawi-Caelen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wenzel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Braun-Falco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ruzicka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>N&#x000f6;then</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Kruse</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Betz</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease.</article-title>
            <source>Br J Dermatol</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>163</volume>
            <issue>1</issue>
            <fpage>197</fpage>
            <page-range>197-200</page-range>
            <pub-id pub-id-type="pmid">20222933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pickup</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Mutasim</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Dowling-Degos disease presenting as hypopigmented macules.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>64</volume>
            <issue>6</issue>
            <fpage>1224</fpage>
            <page-range>1224-5</page-range>
            <pub-id pub-id-type="pmid">21571208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yun</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Roh</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Dowling-Degos disease with fractional Er:YAG laser.</article-title>
            <source>J Cosmet Laser Ther</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>336</fpage>
            <page-range>336-9</page-range>
            <pub-id pub-id-type="pmid">23464495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wenzel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tappe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gerdsen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Uerlich</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Philipp-Dormston</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bieber</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Petrow</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of Dowling-Degos disease with Er:YAG laser.</article-title>
            <source>Dermatol Surg</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>28</volume>
            <issue>8</issue>
            <fpage>748</fpage>
            <page-range>748-50</page-range>
            <pub-id pub-id-type="pmid">12174072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wenzel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Petrow</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Tappe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gerdsen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Uerlich</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Bieber</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Dowling-Degos disease with Er:YAG-laser: results after 2.5 years.</article-title>
            <source>Dermatol Surg</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>29</volume>
            <issue>11</issue>
            <fpage>1161</fpage>
            <page-range>1161-2</page-range>
            <pub-id pub-id-type="pmid">14641349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alshaikh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Alsaif</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Aldukhi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical and Genetic Review of Hereditary Acral Reticulate Pigmentary Disorders.</article-title>
            <source>Dermatol Res Pract</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>3518568</fpage>
            <pub-id pub-id-type="pmid">29201043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCormack</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Cowen</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Haber's syndrome.</article-title>
            <source>Australas J Dermatol</source>
            <year>1997</year>
            <month>May</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>82</fpage>
            <page-range>82-4</page-range>
            <pub-id pub-id-type="pmid">9159964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishizawa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nakano</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Satoh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takayama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sawamura</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yokozeki</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Haber's syndrome may be a clinical entity different from Dowling-Degos disease.</article-title>
            <source>Br J Dermatol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>160</volume>
            <issue>1</issue>
            <fpage>215</fpage>
            <page-range>215-7</page-range>
            <pub-id pub-id-type="pmid">19067693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r14">
          <label>14</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Friedman</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <chapter-title>Neurofibromatosis 1</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>1998</year>
            <month>10</month>
            <day>2</day>
            <pub-id pub-id-type="pmid">20301288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>NU</given-names>
              </name>
              <name>
                <surname>Roach</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alinia</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Current treatment options for acanthosis nigricans.</article-title>
            <source>Clin Cosmet Investig Dermatol</source>
            <year>2018</year>
            <volume>11</volume>
            <fpage>407</fpage>
            <page-range>407-413</page-range>
            <pub-id pub-id-type="pmid">30122971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20316.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basavaraj</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Navya</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rashmi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Relevance of psychiatry in dermatology: Present concepts.</article-title>
            <source>Indian J Psychiatry</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>270</fpage>
            <page-range>270-5</page-range>
            <pub-id pub-id-type="pmid">21180416</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
